GlassScriptPhysician profile
Shuwei Liu
NPI 1770563058
$1,664.94
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $282 · 2021: $40.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $154.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.31 | 2019-2020 | |
| Amgen INC. | $139.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $122.21 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $120.74 | 2019-2020 | |
| Novo Nordisk INC | $104.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $103.64 | 2019 | |
| Vifor Pharma, INC. | $95.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.98 | 2019-2020 | |
| Antares Pharma, INC. | $76.25 | 2019-2020 | |
| Lilly USA, LLC | $75.61 | 2019-2020 | |
| Abbvie INC. | $60.82 | 2019-2021 | |
| Allergan, INC. | $54.87 | 2019-2020 | |
| Pfizer INC. | $54.71 | 2019-2020 | |
| Horizon Therapeutics Plc | $54.18 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $43.17 | 2019-2020 | |
| Astellas Pharma US INC | $36.87 | 2019 | |
| Radius Health, INC. | $28.84 | 2019 | |
| Hologic Sales and Service, LLC | $21.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.53 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.13 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.15 | 2019 | |
| Avion Pharmaceuticals | $13.83 | 2019 | |
| Sanofi Pasteur INC. | $13.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shuwei Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.